Adult-onset idiopathic generalized epilepsy: clinical and behavioral features

Epilepsia. 2001 Nov;42(11):1395-8. doi: 10.1046/j.1528-1157.2001.14901.x.

Abstract

Purpose: To identify and define clinical and behavioral features of patients with adult-onset idiopathic generalized epilepsy (IGE).

Methods: We reviewed the charts of 313 IGE patients at the NYU Comprehensive Epilepsy Center over the past 5 years to identify patients with adult onset (18 years old or older). We excluded patients with childhood or adolescent symptoms that suggested absence, myoclonic, or tonic-clonic seizures, as well as those with a history of significant head injury or other known causes of localization-related epilepsy.

Results: Forty-two (13.4%) patients had a clear onset of IGE in adulthood; average age of onset was early 20s (mean, 23.8 years; range, 18-55 years). Twenty-one patients had adult myoclonic epilepsy (AME, 50%), and three had generalized tonic-clonic seizures on awakening (GTCS-A, 7%). More than two thirds (n=30) are well controlled with current antiepileptic drugs (AEDs), and almost 90% are currently employed (n=37). One third were diagnosed and treated for mental disorders, including depression (n=12), anxiety (n=7), obsessive-compulsive personality disorder (n=2), and postictal psychosis (n=1).

Conclusions: Adult-onset IGE is associated with a good prognosis. An association may exist between psychological disorders, psychotropic medication, and level of seizure control in adults with IGE.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Circadian Rhythm / physiology
  • Electroencephalography / statistics & numerical data
  • Epilepsies, Myoclonic / diagnosis
  • Epilepsies, Myoclonic / drug therapy
  • Epilepsies, Myoclonic / psychology
  • Epilepsy, Generalized / diagnosis*
  • Epilepsy, Generalized / drug therapy
  • Epilepsy, Generalized / psychology
  • Female
  • Humans
  • Medical Records
  • Middle Aged
  • Neuropsychological Tests / statistics & numerical data
  • Prognosis
  • Psychotropic Drugs / therapeutic use
  • Treatment Outcome

Substances

  • Psychotropic Drugs